Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...

Instruct patients to always check the insulin label before injection ... allows substitution at the pharmacy counter for Lantus(R) across the U.S. to help increase access to medicines for people ...

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...

Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved by the FDA in 2021. Merilog, a rapid-acting human insulin analog, is the first ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart) and Eli Lilly's Humalog (insulin lispro) – will be priced at no ...

While long-acting insulin is slow to reach the bloodstream and has a relatively low peak, it stabilizes the “plateau” effect on blood sugar that can last most of the day. Glargine or Lantus is ...

Of the many exciting sneaker releases taking place in San Francisco for NBA All-Star Weekend, perhaps none are more hyped up than Nike's "Black Label" collection. All of Nike's signature athletes ...

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

Food that can support insulin sensitivity include non-starchy vegetables, whole grains, and citrus fruits. People with insulin resistance may also wish to limit sugary drinks and highly processed ...

It causes high blood sugar due to problems making or using insulin in your body ... can be prescribed off-label for polycystic ovarian syndrome (PCOS). PCOS is a hormone disorder that increases ...

With respect to a multiple-unit container such as a typical prescription vial, a prescription label affixed by the pharmacist for a repackaged item should bear a beyond-use date that limits the ...